Skip to content
ClinCalc Pro
Menu
Effervescent potassium replacement

Potassium chloride with potassium bicarbonate

This effervescent oral combination supplies potassium chloride together with potassium bicarbonate to correct hypokalaemia, providing potassium with both chloride and an alkalinising bicarbonate component.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Potassium chloride replaces potassium and chloride, while potassium bicarbonate adds further potassium and a bicarbonate buffer, making the preparation useful where hypokalaemia coexists with a tendency to acidosis rather than alkalosis.

Prescribing in practice

  • Use cautiously in renal impairment and with potassium-sparing diuretics or RAS inhibitors because excess potassium intake can precipitate dangerous hyperkalaemia; the added bicarbonate also makes it unsuitable where alkalosis is present.
  • Dissolve the effervescent tablets fully in water before drinking to reduce gastrointestinal irritation.
  • The bicarbonate content can alter urinary pH and the handling of some other drugs, so consider interactions.

Monitoring

Monitor serum potassium, chloride, bicarbonate and renal function during supplementation.

Counselling the patient

  • Dissolve each tablet completely in water and drink once the fizzing stops.
  • Report palpitations, weakness or tingling, and attend for potassium blood tests.

Evidence & guidelines

Established formulary practice and current prescribing references support such combined potassium salts for oral replacement, with the SPC defining the chloride-plus-bicarbonate niche.

Reference: Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.